Skip to content

The influence of lispro Mix 50/50 and aspart Mix 30/70 on MAGE to diabetes

The influence of lispro Mix 50/50 and aspart Mix 30/70 on MAGE to diabetes

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007340
Enrollment
Unknown
Registered
2015-11-04
Start date
2015-11-09
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

A:lispro Mix 50/50-aspart Mix 30/70
B:aspart Mix 30/70-lispro Mix 50/50

Sponsors

Nanjing First Hospital, Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. voluntary to attend this study signed the informed consent; 2. between 25 and 75 years of age; 3. according to the who standards, the subjects should be diagnosed as type 1/2 diabetes; 4. BMI between 19 and 35kg/m2; 5. stable blood glucose (FBG<=7.0mmol/l PBG<=11.1mmol/L); 6. using enough contraception and not pregnancy; 7. The patients do not attend any medical subjectsin in the last 3 months before enrollment; 8. the subjects agreed to maintain the original diet and exercise habits throughout the study period.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiopulmonary disease; 2. Patients with acute complications (diabetic ketoacidosis, diabetic ketosis hypertonic coma, diabetes lactic acidosis, etc.); 3. Patients with acute infection at the pump withdrawal; 4. Patients with history of mental disease, and not suitable for the use of insulin pump; 5. Researchers think that the patients does not fit for this research (such as alcoholism, drug abuse, etc.).

Design outcomes

Primary

MeasureTime frame
FBG;PBG;CGM;

Secondary

MeasureTime frame
blood routine examination;routine urine test;liver function;ECG;

Countries

China

Contacts

Public ContactJianhua Ma
majianhua@china.com+86 025-86621776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 5, 2026